Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06457204
Status:
COMPLETED
Last Update Posted:
2024-07-15
First Post:
2024-06-10
Brief Title:
A Study in Healthy People to Compare Two Different Sifrol Tablets
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Study Overview
Official Title:
Bioequivalence of Two Sifrol Tablets Following Oral Administration in Healthy Subjects an Open-label Randomised Single-dose Two-way Crossover Trial
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main objective of this trial is to establish the bioequivalence of Sifrol tablets manufactured at two different sites
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2024-510764-23-00 | REGISTRY | None | None |
| U1111-1303-3852 | REGISTRY | WHO Registry ICTRP | None |